SCHEMBL27088332

SCHEMBL27088332

COCCN1CCC(c2cc(-c3ccc(-c4ccn(-c5ccc(F)cc5)c(=O)c4C(N)=O)cc3F)c3c(N)ncnn23)CC1

nearest known ligand 0.70

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ TYRO3 Q06418 20/20 0.70
▸ AXL P30530 3/20 0.58
▸ MERTK Q12866 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27088333 0.95 TYRO3 (0.71) TYRO3AXLMERTK
SCHEMBL28680399 0.94 TYRO3 (0.74) TYRO3AXLMERTK
SCHEMBL28671429 0.92 TYRO3 (0.68) TYRO3AXLMERTK
SCHEMBL29626144 0.91 TYRO3 (0.66) TYRO3AXLMERTK
SCHEMBL29626137 0.88 TYRO3 (0.67) TYRO3AXLMERTK
SCHEMBL29626145 0.88 TYRO3 (0.61) TYRO3AXL
SCHEMBL29626113 0.88 TYRO3 (0.61) TYRO3AXL
SCHEMBL28668424 0.87 TYRO3 (0.74) TYRO3AXLMERTK
SCHEMBL28689844 0.87 TYRO3 (0.69) TYRO3AXLMERTK
SCHEMBL28672697 0.87 TYRO3 (0.68) TYRO3AXLMERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114456175-B Pyrrolotriazine compounds as TAM inhibitors 因赛特公司 2024-09-03 — — CN disclosed
CN-114456176-B Pyrrolotriazine compounds as TAM inhibitors 因赛特公司 2024-08-30 — — CN disclosed
EP-4321513-A2 PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS Incyte Corporation (US) 2024-02-14 — — EP disclosed
CN-114456175-A Pyrrolotriazine compounds as TAM inhibitors 因赛特公司 2022-05-10 — — CN disclosed
CN-114456176-A Pyrrolotriazine compounds as TAM inhibitors 因赛特公司 2022-05-10 — — CN disclosed
CN-109348715-B Pyrrolotriazine compounds as TAM inhibitors 因赛特公司 2021-12-31 — — CN disclosed
Send feedback